Page last updated: 2024-10-17

coumarin and Depressive Disorder, Major

coumarin has been researched along with Depressive Disorder, Major in 1 studies

2H-chromen-2-one: coumarin derivative

Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bleich, S1
Degner, D1
Scheschonka, A1
RĂ¼ther, E1
Kropp, S1

Other Studies

1 other study available for coumarin and Depressive Disorder, Major

ArticleYear
Electroconvulsive therapy and anticoagulation.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2000, Volume: 45, Issue:1

    Topics: Aged; Anticoagulants; Coumarins; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Male

2000